Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 124.49 USD -1.07% Market Closed
Market Cap: 54.9B USD

Intrinsic Value

The intrinsic value of one ZTS stock under the Base Case scenario is 127.97 USD. Compared to the current market price of 124.49 USD, Zoetis Inc is Undervalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ZTS Intrinsic Value
127.97 USD
Undervaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Zoetis Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ZTS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ZTS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Zoetis Inc.

Explain Valuation
Compare ZTS to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

A slowdown in global livestock production, especially in regions struggling with economic headwinds, could dampen demand for Zoetis' core farm-animal health products, limiting volume growth and pressuring margins.

Increasing competition from both established peers and emerging biosimilar developers could lead to pricing pressure on Zoetis’ premium pharmaceuticals and vaccines, siphoning off market share and eroding profitability.

Regulatory hurdles and frequent delays in new product approvals, particularly for novel therapeutics and genetics solutions, may inflate R&D expenses and slow the rollout of high-margin innovation in Zoetis’ pipeline.

Bull Theses

Zoetis’ diverse global presence and balanced portfolio of both companion-animal and livestock products position it to benefit from rising pet ownership trends as well as continued demand for protein worldwide.

Strong relationships with veterinarians and breeders, alongside Zoetis’ targeted customer service and diagnostic offerings, create high switching costs and reinforce the company’s competitive moat in animal health solutions.

Accelerating innovation in genomic testing and digital technologies could unlock new revenue streams and deepen Zoetis’ customer engagement, fueling long-term organic growth through advanced, data-driven products and services.

Show More Less
How do you feel about ZTS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zoetis Inc

Current Assets 6.6B
Cash & Short-Term Investments 2.1B
Receivables 1.5B
Other Current Assets 3B
Non-Current Assets 8.6B
PP&E 3.9B
Intangibles 3.8B
Other Non-Current Assets 880m
Current Liabilities 1.8B
Accounts Payable 410m
Accrued Liabilities 1.1B
Other Current Liabilities 251m
Non-Current Liabilities 8B
Long-Term Debt 7.1B
Other Non-Current Liabilities 885m
Efficiency

Free Cash Flow Analysis
Zoetis Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zoetis Inc

Revenue
9.4B USD
Cost of Revenue
-2.7B USD
Gross Profit
6.7B USD
Operating Expenses
-3.1B USD
Operating Income
3.6B USD
Other Expenses
-943m USD
Net Income
2.7B USD
Fundamental Scores

ZTS Profitability Score
Profitability Due Diligence

Zoetis Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
Positive 3Y Average ROIC
Exceptional Operating Margin
72/100
Profitability
Score

Zoetis Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

ZTS Solvency Score
Solvency Due Diligence

Zoetis Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
High Interest Coverage
Long-Term Solvency
65/100
Solvency
Score

Zoetis Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZTS Price Targets Summary
Zoetis Inc

Wall Street analysts forecast ZTS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZTS is 163.06 USD with a low forecast of 131.3 USD and a high forecast of 210 USD.

Lowest
Price Target
131.3 USD
5% Upside
Average
Price Target
163.06 USD
31% Upside
Highest
Price Target
210 USD
69% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Jan 15, 2026
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for ZTS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ZTS Insider Trading
Buy and sell transactions by insiders

ZTS News

Other Videos
What is the Intrinsic Value of one ZTS stock?

The intrinsic value of one ZTS stock under the Base Case scenario is 127.97 USD.

Is ZTS stock undervalued or overvalued?

Compared to the current market price of 124.49 USD, Zoetis Inc is Undervalued by 3%.

Back to Top